Title | Creator | Relation Is Part Of | ||
---|---|---|---|---|
1 | Bilateral Central Retinal Vein Occlusion In A Patient With Multiple Myeloma | An Vo; Jacqueline M.S. Winterkorn; Szilárd Kiss | NANOS 2014: Poster Presentations | |
2 | Diagnosis & Management of Cavernous Sinus Thrombosis and Infection | John B. Selhorst, MD | 1990 NANOS: Cavernous Sinus Session | |
3 | HIV Infection - Primary Visual Pathways | Nancy J. Newman | 1990 NANOS: AIDS and Lyme Disease Update | |
4 | Infectious Optic Neuropathies: What Should I do Differently? | Lynn K. Gordon | NANOS Annual Meeting 2021: Infectious Diseases in Neuro-Ophthalmology: It's Not Just COVID-19 | |
5 | Infectious Optic Neuropathies: What Should I do Differently? | Lynn K. Gordon | NANOS Annual Meeting 2021: Infectious Diseases in Neuro-Ophthalmology: It's Not Just COVID-19 | |
6 | Infectious Risks With Immunosuppressive Therapy Used to Treat Common Neuro-Ophthalmic Disorders | Lindsey B. De Lott | NANOS Annual Meeting 2021: Infectious Diseases in Neuro-Ophthalmology: It's Not Just COVID-19 | |
7 | Infectious Risks With Immunosuppressive Therapy Used to Treat Common Neuro-Ophthalmic Disorders | Lindsey B. De Lott | NANOS Annual Meeting 2021: Infectious Diseases in Neuro-Ophthalmology: It's Not Just COVID-19 | |
8 | Neuro-Ophthalmic Consequences of Medications for Multiple Sclerosis: The Good, The Bad, The Ugly and The Unknown (abstract) | Heather E. Moss, MD, PhD | NANOS 2017: Neuro-Ophthalmologic Side Effects of More Recently Used Medications in Treating Cancer, Rheumatologic Disorders, and Multiple Sclerosis | |
9 | Neuro-Ophthalmic Consequences of Medications for Multiple Sclerosis: The Good, The Bad, The Ugly and The Unknown (video) | Heather E. Moss, MD, PhD | NANOS Annual Meeting 2017: Neuro-Ophthalmologic Side Effects of More Recently Used Medications in Treating Cancer, Rheumatologic Disorders, and Multiple Sclerosis |